Cancer, Advanced Recruiting Phase 2 Trials for Ipilimumab (DB06186)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02996110A Study to Test Combination Treatments in People With Advanced Renal Cell CarcinomaTreatment
NCT03219775Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell CarcinomaTreatment